Paper · 21428443
Identification of specific inhibitors of human RAD51 recombinase using high-throughput screening.
Huang F and 5 others. ACS Chem Biol, 2011. Cited by 186 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Identification of specific inhibitors of human RAD51 recombinase using high-throughput screening. Papers, record 21428443. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21428443
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Enzyme Inhibitors | Major topic |
| High-Throughput Screening Assays | Major topic |
| Quinazolinones | Major topic |
| Rad51 Recombinase | Major topic |
| Fluorescence Resonance Energy Transfer | |
| Humans | |
| Molecular Structure | |
| Small Molecule Libraries | |
| Stereoisomerism | |
| Structure-Activity Relationship |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA100839 | NCI NIH HHS | United States | R01CA100839 | PubMed and NIH | NIH RePORTER |
| U54 HG003915 | NHGRI NIH HHS | United States | U54HG003915 | PubMed and NIH | NIH RePORTER |
| U54-HG003915 | NHGRI NIH HHS | United States | U54HG003915 | PubMed and NIH | NIH RePORTER |
| MH084119 | NIMH NIH HHS | United States | R03MH084119 | PubMed and NIH | NIH RePORTER |
| R01 CA100839 | NCI NIH HHS | United States | R01CA100839 | PubMed and NIH | NIH RePORTER |
| R56 CA100839 | NCI NIH HHS | United States | R01CA100839 | PubMed and NIH | NIH RePORTER |
| R03 MH084119 | NIMH NIH HHS | United States | R03MH084119 | PubMed and NIH | NIH RePORTER |
| R56CA100839 | NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 156,361 | Purified Escherichia coli recA protein catalyzes homologous pairing of superhelical DNA and single-stranded fragments. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/156361 | PubMed |
| 2 | 18,275,380 | Mechanism of eukaryotic homologous recombination. | Annu Rev Biochem | 2008 | https://conductscience.org/library/papers/18275380 | PubMed |
| 3 | 8,929,543 | Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro. | Cell | 1996 | https://conductscience.org/library/papers/8929543 | PubMed |
| 4 | 9,430,650 | Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death. | EMBO J | 1998 | https://conductscience.org/library/papers/9430650 | PubMed |
| 5 | 17,545,145 | Interactions of human rad54 protein with branched DNA molecules. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17545145 | PubMed |
| 6 | 18,497,811 | Structural biology: snapshots of DNA repair. | Nature | 2008 | https://conductscience.org/library/papers/18497811 | PubMed |
| 7 | 15,226,506 | Ca2+ activates human homologous recombination protein Rad51 by modulating its ATPase activity. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15226506 | PubMed |
| 8 | 11,782,381 | Elevated levels of Rad51 recombination protein in tumor cells. | Cancer Res | 2002 | https://conductscience.org/library/papers/11782381 | PubMed |
| 9 | 16,862,129 | Rad54 protein promotes branch migration of Holliday junctions. | Nature | 2006 | https://conductscience.org/library/papers/16862129 | PubMed |
| 10 | 20,089,461 | Rad54, the motor of homologous recombination. | DNA Repair (Amst) | 2010 | https://conductscience.org/library/papers/20089461 | PubMed |
1 to 10 of 30
See all 30 referencesCited by141
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 186 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,497,248 | BRCA1-RAD51 homologous DNA repair pathway promotes HIV-1 reverse transcription. | Sci Adv | 2026 | https://conductscience.org/library/papers/42497248 | PubMed |
| 42,490,812 | RAD51 in Breast Cancer: From Vulnerability to Resistance. | World J Oncol | 2026 | https://conductscience.org/library/papers/42490812 | PubMed |
| 42,368,572 | RAD51-targeting small molecule degrader sensitizes BRCA-proficient prostate cancer cells to PARP inhibitors via synthetic lethality. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42368572 | PubMed |
| 42,169,779 | Methyltransferase-Like 3 Inhibition-Activated cGAS/STING Axis Enhances Immunotherapy and Poly(ADP-Ribose) Polymerase Inhibitor Sensitivity in Lung Adenocarcinoma. | Research (Wash D C) | 2026 | https://conductscience.org/library/papers/42169779 | PubMed |
| 42,109,249 | TOPBP1-PLK1 interaction preserves genome integrity during mitosis. | Nucleic Acids Res | 2026 | https://conductscience.org/library/papers/42109249 | PubMed |
| 41,514,018 | RPA exhaustion activates SLFN11 to eliminate cells with heightened replication stress. | Nat Cell Biol | 2026 | https://conductscience.org/library/papers/41514018 | PubMed |
| 41,420,106 | Mechanisms of resistance to VHL loss-induced genetic and pharmacological vulnerabilities. | EMBO Mol Med | 2026 | https://conductscience.org/library/papers/41420106 | PubMed |
| 41,372,167 | SLFN11 counteracts the RFWD3-PRIMPOL DNA damage tolerance axis to restrain gapped DNA synthesis in response to replication stress. | Nat Commun | 2025 | https://conductscience.org/library/papers/41372167 | PubMed |
| 41,365,890 | Efficient high-precision transgene knock-in by Recombinases (Redα/β)-enhanced DNA integration-CRISPR-Cas9 (RED-CRISPR). | Nat Commun | 2025 | https://conductscience.org/library/papers/41365890 | PubMed |
| 41,190,241 | Targeting DNA repair mechanisms in cancer therapy: the role of small molecule DNA repair inhibitors. | NAR Cancer | 2025 | https://conductscience.org/library/papers/41190241 | PubMed |
1 to 10 of 141
See all 141 cited byGenes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BRCA1 | 672 | PubTator's text mining | https://conductscience.org/library/genes/672 | NCBI Gene |
| RAD51 | 5,888 | PubTator's text mining | https://conductscience.org/library/genes/5888 | NCBI Gene |
| RAD54L | 8,438 | PubTator's text mining | https://conductscience.org/library/genes/8438 | NCBI Gene |
| SMARCA4 | 6,597 | PubTator's text mining | https://conductscience.org/library/genes/6597 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21428443
GET https://conductscience.org/api/papers/v1/21428443/references?page=2